Functional Imaging of Dopaminergic Neurotransmission in Tourette Syndrome

Albin, 2003, Increased ventral striatal monoaminergic innervation in Tourette syndrome, Neurology, 61, 310, 10.1212/01.WNL.0000076181.39162.FC Albin, 2009, Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome, Neurology, 72, 1390, 10.1212/WNL.0b013e3181a187dd Behen, 2007, Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome, Movement Disorders: Official Journal of the Movement Disorder Society, 22, 2256, 10.1002/mds.21712 Braun, 1995, The functional anatomy of Tourette’s syndrome: An FDG-PET study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 13, 151, 10.1016/0893-133X(95)00052-F Braun, 1993, The functional neuroanatomy of Tourette’s syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 9, 277, 10.1038/npp.1993.64 Buse, 2013, Neuromodulation in Tourette syndrome: Dopamine and beyond, Neuroscience & Biobehavioral Reviews, 37, 1069, 10.1016/j.neubiorev.2012.10.004 Cheon, 2004, Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette’s disorder, Psychiatry Research, 130, 85, 10.1016/j.pscychresns.2003.06.001 Eidelberg, 1997, The metabolic anatomy of Tourette’s syndrome, Neurology, 48, 927, 10.1212/WNL.48.4.927 Ernst, 1999, High presynaptic dopaminergic activity in children with Tourette’s disorder, Journal of the American Academy of Child and Adolescent Psychiatry, 38, 86, 10.1097/00004583-199901000-00024 Georges, 1992, A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette’s syndrome and obsessive compulsive disorder, Journal of Clinical Psychiatry, 53, 370 Gilbert, 2006, Altered mesolimbocortical and thalamic dopamine in Tourette syndrome, Neurology, 67, 1695, 10.1212/01.wnl.0000242733.18534.2c Grace, 1991, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia, Neuroscience, 41, 1, 10.1016/0306-4522(91)90196-U Grace, 1995, The tonic/phasic model of dopamine system regulation: Its relevance for understanding how stimulant abuse can alter basal ganglia function, Drug and Alcohol Dependence, 37, 111, 10.1016/0376-8716(94)01066-T Haugbol, 2007, Cerebral 5-HT2A receptor binding is increased in patients with Tourette syndrome, The International Journal of Neuropsychopharmacology: The Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (NCIP), 10, 245, 10.1017/S1461145706006559 Heinz, 1998, Tourette’s syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity, Neurology, 51, 1069, 10.1212/WNL.51.4.1069 Hwang, 2008, [99mTc]TRODAT-1/[1231]IBZM SPECT studies of the dopaminergic system in Tourette syndrome, Psychiatry Research, 162, 159, 10.1016/j.pscychresns.2007.04.006 Jeffries, 2002, The functional neuroanatomy of Tourette’s syndrome: An FDG PET study III: Functional coupling of regional cerebral metabolic rates, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 27, 92, 10.1016/S0893-133X(01)00428-6 Lampreave, 1998, Technetium-99m-HMPAO in Tourette’s syndrome on neuroleptic therapy and after withdrawal, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 39, 624 Lerner, 2007, Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome, Neurology, 68, 1979, 10.1212/01.wnl.0000264417.18604.12 Liu, 2010, Evaluation of Tourette’s syndrome by (99m)Tc-TRODAT-1 SPECT/CT imaging, Annals of Nuclear Medicine, 24, 515, 10.1007/s12149-010-0389-3 Malison, 1995, [1231]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette’s disorder, The American Journal of Psychiatry, 152, 1359, 10.1176/ajp.152.9.1359 Meyer, 1999, Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome, Neurology, 52, 371, 10.1212/WNL.53.2.371 Mizner, 2004, Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum, Journal of the Neurological Sciences, 219, 55 Moriarty, 1995, Brain perfusion abnormalities in Gilles de la Tourette’s syndrome, The British Journal of Psychiatry: The Journal of Mental Science, 167, 249, 10.1192/bjp.167.2.249 Müller-Vahl, 2000, Dopamine transporter binding in Gilles de la Tourette syndrome, Journal of Neurology, 247, 514, 10.1007/PL00007806 Müller-Vahl, 2000, Dopamine D2 receptor imaging in Gilles de la Tourette syndrome, Acta Neurologica Scandinavica, 101, 165, 10.1034/j.1600-0404.2000.101003165.x Pourfar, 2011, Abnormal metabolic brain networks in Tourette syndrome, Neurology, 76, 944, 10.1212/WNL.0b013e3182104106 Riddle, 1992, SPECT imaging of cerebral blood flow in Tourette syndrome, Advances in Neurology, 51, 207 Roessner, 2011, European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment, European Child & Adolescent Psychiatry, 20, 173, 10.1007/s00787-011-0163-7 Saporta, 2010, Multimodality neuroimaging in Tourette syndrome: Alpha-[11C] methyl-l-tryptophan positron emission tomography and diffusion tensor imaging studies, Journal of Child Neurology, 25, 336, 10.1177/0883073809339394 Serra-Mestres, 2004, Dopamine transporter binding in Gilles de la Tourette syndrome: A [1231]FP-CIT/SPECT study, Acta Psychiatrica Scandinavica, 109, 140, 10.1111/j.0001-690X.2004.00214.x Singer, 1991, Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette’s syndrome, Annals of Neurology, 30, 558, 10.1002/ana.410300408 Singer, 2002, Elevated intrasynaptic dopamine release in Tourette’s syndrome measured by PET, The American Journal of Psychiatry, 159, 1329, 10.1176/appi.ajp.159.8.1329 Stamenkovic, 2001, No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: A [(123)I]-beta-CIT SPECT-study, European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 11, 69, 10.1016/S0924-977X(00)00134-6 Steeves, 2010, Extrastriatal dopaminergic dysfunction in Tourette syndrome, Annals of Neurology, 67, 170, 10.1002/ana.21809 Stern, 2000, A functional neuroanatomy of tics in Tourette syndrome, Archives of General Psychiatry, 57, 741, 10.1001/archpsyc.57.8.741 Stoetter, 1992, Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET, Advances in Neurology, 58, 213 Turjanski, 1994, PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette’s syndrome, Journal of Neurology, Neurosurgery, and Psychiatry, 57, 688, 10.1136/jnnp.57.6.688 Wolf, 1996, Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding, Science, 273, 1225, 10.1126/science.273.5279.1225 Wong, 2008, Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: Clues from an in vivo neurochemistry study with PET, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 33, 1239, 10.1038/sj.npp.1301528 Yeh, 2006, Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette’s adults, Nuclear Medicine Communications, 27, 779, 10.1097/01.mnm.0000239485.53780.16 Yeh, 2007, Phasic dysfunction of dopamine transmission in Tourette’s syndrome evaluated with 99mTc TRODAT-1 imaging, Psychiatry Research, 156, 75, 10.1016/j.pscychresns.2007.01.003 Yoon, 2007, Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis, Journal of the Neurological Sciences, 255, 50, 10.1016/j.jns.2007.01.069